INIS
cancer
100%
drugs
95%
genes
77%
atp
63%
glycoproteins
46%
chemotherapy
40%
humans
33%
proteins
33%
tumors
29%
melanomas
28%
patients
27%
nucleotides
17%
doxorubicin
16%
substrates
15%
ovaries
13%
myeloid leukemia
13%
in vitro
13%
antineoplastic drugs
12%
dna
12%
mutations
12%
stem cells
12%
apoptosis
11%
data
11%
breasts
10%
reviews
10%
mutants
10%
range
10%
toxicity
10%
regulations
10%
density
10%
mice
9%
platinum
9%
glutathione
9%
levels
9%
tools
9%
origin
8%
comparative evaluations
8%
sensitivity
8%
capacity
8%
metabolism
8%
evaluation
7%
histones
7%
diseases
7%
migration
7%
molecules
7%
hiv
6%
inventions
6%
chemistry
6%
enrichment
6%
yields
6%
Keyphrases
Multidrug Resistance
22%
ATP-binding Cassette Transporter A1 (ABCA1)
13%
Cancer Stem Cells
13%
ABC Transporter Gene
9%
Cancer Types
8%
Invasive Ability
6%
Exome Sequencing
6%
DNA Microarray
6%
Recurrent Melanoma
6%
Environmental Adversity
6%
Cancer Resistance
6%
Immune System Response
6%
Cellular Pharmacology
6%
Regulatory Change
6%
Tumor Cell Heterogeneity
6%
Hydrodynamic Behavior
6%
Dynamic Variation
6%
Neighboring Cells
6%
Tumor Behavior
6%
Differentiation Pathway
6%
P-gp Expression
6%
Monogenic
6%
Recessive Disorder
6%
Complex Disease
6%
Romidepsin
6%
Histone Deacetylase Inhibitor (HDACi)
6%
MEK Inhibitor (MEKi)
6%
Chemotherapy-induced
6%
Pathway Activation
6%
Inhibitor Resistance
6%
Gene Signature
6%
Biological Heterogeneity
6%
Relapsed or Refractory Acute Myeloid Leukemia
6%
Ovarian Serous Carcinoma
6%
Overall Survival of Patients
6%
Home Cage
6%
Continuous Observation
6%
Vivarium
6%
Rack
6%
Video Monitoring
6%
Cage Environment
6%
Laboratory Mice
6%
Dendritic Cell Migration
6%
Transporter Genes
6%
Successful Treatment
6%
Acute Myeloid Leukemia
6%
ABCA3
6%
Human Dendritic Cells
6%
ABCC4
6%
Mrp4
6%
Biochemistry, Genetics and Molecular Biology
Multidrug Resistance
34%
ABC Transporter
30%
ATP-binding Cassette Transporter
29%
ABCB5
21%
Cancer Cell
16%
Isoform
15%
Drug Resistance
15%
P-Glycoprotein
13%
Adenosine Triphosphate
8%
ABCG2
7%
Binding Domain
7%
Carcinogenesis
6%
Drug Binding
6%
ABCA3
6%
Quantitative Technique
6%
MEK Inhibitor
6%
Histone Deacetylase
6%
Romidepsin
6%
Overall Survival
6%
Experimental Mouse
6%
Dendritic Cell
6%
Melanogenesis
6%
Cisplatin
6%
AMP-activated Protein Kinase
6%
Myeloid
6%
TRAIL
6%
